Medis Technologies to Present at Roth Capital Partners 17th Annual Growth Stock Conference.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Medis Technologies Ltd. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :MDTL MDTL Medis Technologies, Ltd (stock symbol) MDTL Montana Defense Trial Lawyers Association ) today announced that the Company is scheduled to present at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, 17th Annual Growth Stock Conference on Tuesday, February 22, 2005 at 5:00 pm Eastern Time / 2:00 pm Pacific Time. The conference is being held at the St. Regis Monarch Beach Resort & Spa in Dana Point, CA. Medis will be presenting in the "Aegean" room. The presentation will also be broadcast live over the Internet via the home page of Medis' website - www.medistechnologies.com. To listen to the live call, go to the website at least 15 minutes early to register, download and install any necessary audio software. You can also access the webcast and replay at http://www.wsw.com/webcast/roth5/mdtl/. For more information about the conference visit: http://www.rothcp.com/2005%20DP%20Conference%20Web%20Site/ Roth%20DP.html?content=home. Medis Technologies is involved in the development of highly advanced proprietary technology products primarily related to sources of clean energy for the 21st Century. Medis' primary focus is on direct liquid fuel cell technology. Its business strategy is to license or sell its technologies to, or enter into joint ventures with, large international corporations or sell its products to end users through retail outlets and service providers. In addition to its fuel cell technology, Medis' product pipeline, in varying stages of development, includes inherently conductive polymers, the toroidal engine and compressor and stirling cycle system. Medis has also developed the CellScan with many potential applications relating to disease diagnostics and chemo che·mo n. Chemotherapy or a chemotherapeutic treatment. sensitivity. This press release may contain forward-looking statements, which are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements involve risk and uncertainties, including, but not limited to, the successful completion of product development, the success of product tests, commercialization risks, availability of financing and results of financing efforts. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC. This press release is available on Medis' web site at www.medistechnologies.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion